Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China flag China · Delayed Price · Currency is CNY
26.92
+0.38 (1.43%)
At close: Apr 30, 2026

SHE:301089 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
115.67140.2669.23148.55307.09284.22
Trading Asset Securities
115.56105.15250.88190.7240.16220.62
Cash & Short-Term Investments
231.23245.41320.11339.26547.25504.84
Cash Growth
-17.86%-23.34%-5.64%-38.01%8.40%219.08%
Accounts Receivable
119.59126.13151.52235.3205.41103.58
Other Receivables
0.1723.821.3212.5713.660.62
Receivables
119.76149.93172.84247.87219.07104.2
Inventory
196.29181.61178.88204.11241.14167.08
Other Current Assets
33.1285.1830.936.5420.64
Total Current Assets
580.41584.95677.01822.171,014796.76
Property, Plant & Equipment
849.25862.77874.54809.38610.26449.11
Long-Term Investments
19.719.77.958.3710.8612.54
Other Intangible Assets
79.4280.1281.8384.0484.2684.56
Long-Term Accounts Receivable
-0.270.26---
Long-Term Deferred Tax Assets
74.0870.9869.5863.7170.366.51
Long-Term Deferred Charges
3.383.6242.71.862.33
Other Long-Term Assets
44.7442.8943.0848.6251.6441.9
Total Assets
1,6511,6651,7581,8391,8431,394
Accounts Payable
109.38118.01133.21152.55158.58162.94
Accrued Expenses
8.6917.3122.8124.5869.0917.51
Short-Term Debt
----40.0364.5
Current Portion of Long-Term Debt
1.02-----
Current Portion of Leases
-1.010.97--4.91
Current Income Taxes Payable
2.40-066.051.31
Current Unearned Revenue
5.741.690.915.4871.892.9
Other Current Liabilities
14.087.947.4311.918.320.53
Total Current Liabilities
141.32145.97165.32194.51423.96254.6
Long-Term Leases
2.262.243.25---
Long-Term Unearned Revenue
30.130.5532.9435.1738.3140.4
Long-Term Deferred Tax Liabilities
2.392.364.216.044.611.36
Total Liabilities
176.07181.12205.72235.72466.89296.35
Common Stock
126.54126.54126.54126.54126126
Additional Paid-In Capital
621.11621.11621.11621.11585.3578.54
Retained Earnings
722.48732.99802.66854.18661.5387.57
Comprehensive Income & Other
4.763.532.211.443.575.25
Total Common Equity
1,4751,4841,5531,6031,3761,097
Shareholders' Equity
1,4751,4841,5531,6031,3761,097
Total Liabilities & Equity
1,6511,6651,7581,8391,8431,394
Total Debt
3.283.254.22-40.0369.41
Net Cash (Debt)
227.95242.16315.89339.26507.22435.43
Net Cash Growth
-17.78%-23.34%-6.89%-33.11%16.49%-
Net Cash Per Share
1.761.912.542.694.024.37
Filing Date Shares Outstanding
131.37126.54126.54126.54126126
Total Common Shares Outstanding
131.37126.54126.54126.54126126
Working Capital
439.09438.98511.69627.66590.04542.16
Book Value Per Share
11.2311.7312.2712.6710.928.71
Tangible Book Value
1,3951,4041,4711,5191,2921,013
Tangible Book Value Per Share
10.6211.1011.6212.0110.258.04
Buildings
-424.24283.94267.66257.26210.62
Machinery
-657.07420.02382.3354.84301.65
Construction In Progress
-44.71372.68331.03130.4835.59
Source: S&P Global Market Intelligence. Standard template. Financial Sources.